Skip to main content
Fig. 3 | Child and Adolescent Psychiatry and Mental Health

Fig. 3

From: Cognitive functions following initiation of antipsychotic medication in adolescents and adults at clinical high risk for psychosis: a naturalistic sub group analysis using the MATRICS consensus cognitive battery

Fig. 3

Mean score trajectories for clinical features and neurocognitive performances based on the repeated-measures analysis of variance, compared between AP− and AP+, Ado and Adu groups at baseline and follow-up. AP− treated without antipsychotic medication, AP+ treated with antipsychotic medication, BACS brief assessment of cognition in Schizophrenia symbol coding, BVMT-R brief visuospatial memory test-revised, CPT-IP continuous performance test-identical pairs, HVLT-R Hopkins verbal learning test-revised, NAB neuropsychological assessment battery mazes, WMS-3 Wechsler memory scale–third edition spatial span. *p < 0.05; **p < 0.01; ***p < 0.001

Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000